Abstract A095: Enhancing minority patient participation in tobacco cessation by a personal pathway to success program
Abstract
Background: Minority cancer patients (pts) who use tobacco often decline tobacco cessation programs due to variable personal barriers and priorities. We developed a Personal Pathway to Success (PPS) program to overcome barriers and improve patient (pt) engagement. PPS allowed pts to choose cessation components they were willing to initially use. Methods: City of Hope (COH) tobacco cessation program developed a comprehensive list of evidence-based cessation services. Pts completed tobacco use and a Lifestress Scale assessing societal determinants of distress. PPS was then tailored and offered to pts to create their iquit strategy. Pts could add or delete components at any time as engaged partners in cessation care. Pts were evaluated by demographic group. Since tobacco use is associated with adverse surgical outcomes, we tested the PPS program in the preoperative anesthesia testing clinic (PATC). Results were compared by Chi square statistics. Study data collection was 9/2021 to 2/2022. Results: The components of PPS were individual cessation counseling, individual motivational counseling, nicotine replacement and cessation medications, signed personal commitment agreement, English and Spanish cessation support groups, choosing a buddy partner (family, friends or support group), lung cancer screening, letter to primary care physicians requesting assistance for non-responding pts, SmokeFree Text support, Kick It California or Asian Smokers' Quitline support, rapid action plan…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.